Literature DB >> 19379776

Animal models of gene-environment interactions in schizophrenia.

Yavuz Ayhan1, Akira Sawa, Christopher A Ross, Mikhail V Pletnikov.   

Abstract

The pathogenesis of schizophrenia and related mental illnesses likely involves multiple interactions between susceptibility genes of small effects and environmental factors. Gene-environment interactions occur across different stages of neurodevelopment to produce heterogeneous clinical and pathological manifestations of the disease. The main obstacle for mechanistic studies of gene-environment interplay has been the paucity of appropriate experimental systems for elucidating the molecular pathways that mediate gene-environment interactions relevant to schizophrenia. Recent advances in psychiatric genetics and a plethora of experimental data from animal studies allow us to suggest a new approach to gene-environment interactions in schizophrenia. We propose that animal models based on identified genetic mutations and measurable environment factors will help advance studies of the molecular mechanisms of gene-environment interplay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19379776      PMCID: PMC2735613          DOI: 10.1016/j.bbr.2009.04.010

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  133 in total

Review 1.  Neurobiology of schizophrenia.

Authors:  Christopher A Ross; Russell L Margolis; Sarah A J Reading; Mikhail Pletnikov; Joseph T Coyle
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

2.  Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.

Authors:  Paul D Shilling; Richard L Saint Marie; Jody M Shoemaker; Neal R Swerdlow
Journal:  Biol Psychiatry       Date:  2008-02-20       Impact factor: 13.382

Review 3.  Modeling madness in mice: one piece at a time.

Authors:  P Alexander Arguello; Joseph A Gogos
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

4.  An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.

Authors:  Cécile Henquet; Araceli Rosa; Lydia Krabbendam; Sergi Papiol; Lourdes Fananás; Marjan Drukker; Johannes G Ramaekers; Jim van Os
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

Review 5.  Reelin, lipoprotein receptors and synaptic plasticity.

Authors:  Joachim Herz; Ying Chen
Journal:  Nat Rev Neurosci       Date:  2006-11       Impact factor: 34.870

6.  Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach.

Authors:  Eric Q Wu; Lizheng Shi; Howard Birnbaum; Teresa Hudson; Ronald Kessler
Journal:  Psychol Med       Date:  2006-08-15       Impact factor: 7.723

Review 7.  Substance-induced psychosis: a diagnostic conundrum.

Authors:  Steve Mathias; Dan I Lubman; Leanne Hides
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

Review 8.  Cannabis, cannabinoids and schizophrenia: integration of the evidence.

Authors:  Martin Cohen; Nadia Solowij; Vaughan Carr
Journal:  Aust N Z J Psychiatry       Date:  2008-05       Impact factor: 5.744

Review 9.  Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.

Authors:  Vera Bubeníková-Valesová; Jirí Horácek; Monika Vrajová; Cyril Höschl
Journal:  Neurosci Biobehav Rev       Date:  2008-04-08       Impact factor: 8.989

Review 10.  TLR3: interferon induction by double-stranded RNA including poly(I:C).

Authors:  Misako Matsumoto; Tsukasa Seya
Journal:  Adv Drug Deliv Rev       Date:  2008-01-02       Impact factor: 15.470

View more
  26 in total

1.  Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.

Authors:  Ana Pocivavsek; Hui-Qiu Wu; Greg I Elmer; John P Bruno; Robert Schwarcz
Journal:  Eur J Neurosci       Date:  2012-04-20       Impact factor: 3.386

Review 2.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

Review 3.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

Review 4.  Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Authors:  Chi-Ying Lin; Akira Sawa; Hanna Jaaro-Peled
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

Review 5.  The conundrums of understanding genetic risks for autism spectrum disorders.

Authors:  Matthew W State; Pat Levitt
Journal:  Nat Neurosci       Date:  2011-10-30       Impact factor: 24.884

Review 6.  Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.

Authors:  Caline S Karam; Jacob S Ballon; Nancy M Bivens; Zachary Freyberg; Ragy R Girgis; José E Lizardi-Ortiz; Sander Markx; Jeffrey A Lieberman; Jonathan A Javitch
Journal:  Trends Pharmacol Sci       Date:  2010-06-25       Impact factor: 14.819

7.  Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders.

Authors:  Hanna E Stevens; Karen M Smith; Brian G Rash; Flora M Vaccarino
Journal:  Front Neurosci       Date:  2010-09-01       Impact factor: 4.677

8.  Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study.

Authors:  Bagrat Abazyan; Jenifer Dziedzic; Kegang Hua; Sofya Abazyan; Chunxia Yang; Susumu Mori; Mikhail V Pletnikov; Tomas R Guilarte
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

9.  Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.

Authors:  Peter L Oliver; Kay E Davies
Journal:  Hum Mol Genet       Date:  2009-09-03       Impact factor: 6.150

10.  Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders.

Authors:  Y Ayhan; B Abazyan; J Nomura; R Kim; B Ladenheim; I N Krasnova; A Sawa; R L Margolis; J L Cadet; S Mori; M W Vogel; C A Ross; M V Pletnikov
Journal:  Mol Psychiatry       Date:  2010-01-05       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.